Director, Interventional Cardiology
OHSU
Dr. Zahr is an Associate Professor in the Knight Cardiovascualt Institute of Oregon Health & Science University. He is the the director of Interventional Cardiology and Co-Director of the Structural Heart Disease program. His main research interest is minimally invasive therapies for valvular heart disease.
Disclosure(s): Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medronic: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Saturday, March 8, 2025
10:28 AM – 10:36 AM ET
Saturday, March 8, 2025
4:09 PM – 4:17 PM ET
The INTREPID Valve for Severe Tricuspid Regurgitation | Case Experience
Saturday, March 8, 2025
3:38 PM – 3:46 PM ET
Panel Discussion | Opportunities and Barriers of TMVR
Sunday, March 9, 2025
9:20 AM – 9:35 AM ET
APOLLO | Making the Case for the RCT - Are We Ready for TMVR Versus TEER?
Sunday, March 9, 2025
11:16 AM – 11:24 AM ET
Panel Discussion: What Is the Best Management of MR | Percutaneous Valve Repair or Replacement?
Sunday, March 9, 2025
11:40 AM – 12:05 PM ET
Mitral Repair and Replacement | State of the Field
Monday, March 10, 2025
9:45 AM – 10:00 AM ET
Live Case from Providence Swedish Heart and Vascular | Seattle, WA
Monday, March 10, 2025
10:00 AM – 10:45 AM ET
Endovascular Solutions Allow for Minimally Invasive MVR for Small LVOT
Monday, March 10, 2025
11:08 AM – 11:16 AM ET
Monday, March 10, 2025
7:00 PM – 7:30 PM ET
Tuesday, March 11, 2025
10:00 AM – 10:20 AM ET